As the population ages, the prevalence of osteoporosis increases with resultant increase in the risks of bone fractures. We are also referring more people for assessment of bone mineral density, thereby able to find asymptomatic persons with low bone mineral density. This brings the dilemma of whether to treat or not to treat and, if so, when to do so.

Profs. Andrew Borg, Consultant Rheumatologist, clarifies the issues relating to the prophylactic use of bisphosphonates in post-menopausal osteoporotic women.

  

Subscribe to TheSynapse YouTube Channel

Click to view the video

[iframe width=”100%” height=”415″ src=”//www.youtube.com/embed/gOg5ICrFYls” frameborder=”0″ allowfullscreen ]